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Abstract
Background: The prevalence of obesity is considered to be increased worldwide. Lack of mineral elements is one
of the essential side effects of bariatric surgery as a trending treatment for obesity. We aimed to assess zinc
deficiency among morbidly obese patients before and following different types of bariatric surgical procedures.
Methods: In the present retrospective cohort study, 413 morbidly obese patients (body mass index (BMI) ≥ 40 kg/
m2 or BMI ≥ 35 kg/m2 with a complication or risk factor, e.g., diabetes mellitus) were enrolled who received
bariatric surgery, aged between 18 and 65 years old, and had a negative history of active consumption of alcohol
and illicit drugs. Patients were assigned into three groups of bariatric surgeries: mini-gastric bypass, Roux-en-Y
gastric bypass (RYGB), and sleeve gastrectomy (SG). We recorded baseline clinical and demographic characteristics
and zinc serum levels during the preoperative and postoperative follow-up periods at three, six, and 12 months
after the operation.
Results: All patients with a mean age of 40.57 ± 10.63 years and a mean preoperative BMI of 45.78 ± 6.02 kg/m2
underwent bariatric surgery. 10.2% of the bariatric patients experienced zinc deficiency before the surgery, and
27.1% at 1 year after the surgery. The results showed that 27.7% of mini-gastric bypass patients, 29.8% of RYGB, and
13.3% of SG experienced zinc deficiency 12 months following surgery. We observed no statistical differences in the
preoperative and postoperative zinc deficiency between different types of surgeries.
Conclusion: A high prevalence of preoperative zinc deficiency among morbidly obese patients who underwent
bariatric surgery was observed, which increased during the postoperative periods. We recommend assessing zinc
serum levels and prescribing zinc supplements before the bariatric operation to alleviate the prevalence of zinc
deficiency after the operation.
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Introduction
Obesity, as one of the most crucial health issues world-
wide, is considered a modifiable and preventable risk
factor for many diseases. The increased rate of obesity
raises the mortality and morbidity rates in populations.
The main consequences are cardiovascular diseases,
cerebrovascular accidents and strokes,, and cancer types
[1]. Approximately 600 million people are obese globally,
and the prevalence of obesity in Iran was reported by
21.4% in 2019 [2]. Bariatric surgery is a trend for obesity
treatment recently. Several types of bariatric operation-
sare classified into restrictive procedures, including
sleeve gastrectomy (SG), malabsorptive procedures, such
as biliopancreatic diversion with or without a duodenal
switch, and combined procedures, like Roux-en-Y gastric
bypass (RYGB) and mini-gastric bypass [3].
The trace elements, including zinc, copper, selenium,
and iron, playan essential role in biomedical pathways
for cell function and metabolism in cells [4]. Zinc is a
catalytic component of many metalloenzymesand tran-
scription factors found in all body tissues, fluids, and se-
cretions [5]. The zinc serum levels are reduced in
obesity, indicating the correlation of zinc deficiency and
obesity-related complications such as insulin resistance
[6]. The serum zinc levels are the main pool of available
zinc in the human body. Therefore, zinc deficiency could
affect zinc hemostasis [7]. The zinc deficiency can cause
hair loss, diarrhea, glossitis, nail dystrophy, hypogonad-
isms in males, infertility, and anemia, delayed wound
healing, skin lesion, and taste alteration [8]. The lack of
micronutrients reported in most studies is one of the
common complications after bariatric surgery. One of
them is the four-year follow-up of 65 obese patients after
bariatric surgery that showed basal deficiencies in obese
patients, which is increased after bariatric surgery [9].
This study aimed to assess the zinc deficiency in
morbidly obese patients after bariatric surgeries and its
changes according to the types of surgical procedures
among the Iranian population.
Main text
Methods
We conducted a retrospective cohort study at the obes-
ity center of RasoulAkramHospital, Tehran, Iran, from-
December2018 to December2019. We recruited 413
morbidly obese patients (body mass index (BMI) ≥ 40 kg/
m2 or BMI ≥ 35 kg/m2 with a complication or risk factor,
e.g., DM) who underwent bariatric surgery, aged be-
tween 18 and 65 years old, and did not actively consume
alcohol and illicit drugs. Patients who had a history of
bariatric surgery were excluded. The Ethics Committee
of Iran University of Medical Sciences approved the
present study (Ethics code: IR.IUMS.REC 1396.31866).
We assigned the patients into three groups according
to the type of bariatric surgery (mini-gastric bypass,
RYGB, and SG). We recorded zinc serum levels during
the preoperative period and follow-up measurements at
three, six, and 12months after the surgery. The refer-
ence value for zinc serum levels is 70-120 μg/dl [10].
Baseline clinical and demographic features were also
recorded on a checklist.
At the first postoperative visit (2–3 weeks after the
operation), we encouraged the patients to take multivita-
min and mineral supplementations postoperatively (one
tablet orally daily), which contained30mg zinc as zinc
oxide per tablet alongside other vitamins and micronu-
trients, presented in Table 1.
Statistical analysis
We performed statistical analyses using IBM SPSS statis-
tics version 19. Continuous variables were demonstrated
as mean ± standard deviation (SD) or median and cat-
egorical values as percentages or absolute values. To
compare continuous variables, we used ANOVA or
Kruskal-Wallis test based on the assumptions of the
former. In case the ANOVA or Kruskal-Wallis test met
the significant levels, we performed Tukey post hoc test.
We made a comparison of categorical values by Chi-
square or Fisher’s exact tests. We considered 2-tailed p
values of < 0.05 statistically significant.
Results
Demographics
Four hundred thirteen (413) patients met the inclusion
criteria, and their demographic information is shown in
Table 2. In Total, all patients with a mean age of
40.57 ± 10.63 years and a mean preoperative BMI of
45.78 ± 6.02 kg/m2underwent bariatric surgery. Signifi-
cantly more patients were female (334, 83.3%), and more
underwent mini-gastric bypass than RYGB or SG (289,
94, and 30, respectively). The ANOVA test for age be-
tween surgical groups was not significant (P-value:
0.413). The frequency of comorbidities, including
hypertension, DM type II, hyperlipidemia, and
hypothyroidism, were summarized in Table 1. Hyperlip-
idemia was the most common comorbidity in all patients
(188/413).
Zinc serum levels and zinc deficiency
The mean preoperativezinc plasma concentration was
89.96 ± 21.4 μg/dl. Thezincserum level after surgery was
significantly decreased in patients (P-value< 0.001), with
statistically significant differences between the preopera-
tive period and the six and 12 months after the oper-
ation, as well as between the third postoperative month
and the six and 12months after the operation. There
was an association between BMI groups and zinc serum
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levels (P-value: 0.044), with a statistical difference be-
tween 40 ≤ BMI ≤ 50 and BMI > 50 groups. Furthermore,
the association between sex and zinc serum levels was
significant (P-value: 0.038). The data weresummarized in
Table 3. There was no association between zinc serum
levels and any comorbidities. However,there was a sig-
nificant association between impaired FBS, DM type II,
and zinc deficiency (P-value: 0.027, and 0.047, respect-
ively). The zinc plasma concentration was shown in
Table S1 (Supplementary file: Tables) based on the type
of bariatric procedures. At 12 months of surgery, the
zinc serum level presented significantly lower in the
mini-gastric bypass compared to the other types of sur-
geries. We compared zinc deficiency between groups of
bariatric surgery before and after the operation, shown
in Table S2 (Supplementary file: Tables)). The results
showed that at 12 months after operation, 27.7% of the
patients who underwent mini-gastric bypass, 29.8% of
RYGB, and 13.3% of SG experienced zinc deficiency.
However, no significant difference in zinc deficiency be-
tween different types of surgery was observed.
Discussion
In the current study, we demonstrated that bariatric pa-
tients tended to show a high proportion of zinc defi-
ciency increased from 10.2% in the preoperative period
to 27.1% at 1 year after the surgery. There are reports
which presented a high prevalence of zinc deficiency
among obese patients during the preoperative period
[11–15]. Previous studies have represented the following
Table 1 Ingredients of multivitamin and mineral supplementation
Nutrient Amount per tablet
Vitamin A (as Retinyl Acetate and Beta Carotene) 2250 μg
Vitamin C (Ascorbic acid) 90mg
Vitamin D (as Cholecalciferol) 75 μg
Vitamin E (as D-Alpha Tocopheryl Succinate) 40.2 μg
Vitamin K (as Phytonadione) 160 μg
Thiamin (as Thiamin HCl) 3 mg
Riboflavin 3.4 mg
Niacin (as Niacinamide) 20mg
Vitamin B6 (as Pyridoxine HCl) 4 mg
Folate (as Folic Acid) 800 μg
Vitamin B12 (as Cyanocobalamin) 500 μg
Biotin 600 μg
Pantothenic acid (as Calcium D-Pantothenate) 20mg
Iron (as Ferrous Fumarate) 45mg
Iodine (as Potassium Iodide) 150 μg
Magnesium (as Magnesium Oxide) 400mg
Zinc (as Zinc Oxide) 30mg
Selenium (as L-Selenomethionine) 70 μg
Copper (as Cupric Oxide) 2 mg
Manganese (as Manganese Sulfate) 2 mg
Chromium (as Chromium Picolinate) 120 μg
Molybdenum (as Sodium Molybdate) 75 μg
Table 2 Demographic and clinical characteristics
Characteristic
Age (years), mean (SD) 40.57 (10.63)
Sex, female, n (%) 344 (83.3)
Preoperative BMI (kg/m2), mean (SD) 45.78 (6.02)
Type of bariatric surgery, n (%)
Mini-gastric bypass 289 (70)
RYGB 94 (22.8)
SG 30 (7.2)
HTN, n (%) 79 (19.1)
Impaired FBS, n (%) 76 (18.4)
DM type II, n (%) 76 (18.4)
Dyslipidemia, n (%) 188 (45.5)
Hypothyroidism, n (%) 91 (22)
Abbreviations: BMI Body mass index, RYGB Roux-en-Y gastric bypass, SG Sleeve
gastrectomy, HTN Hypertension, FBS Fasting blood sugar, DM Diabetes
mellitus, SD Standard deviation
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reasons for explaining zinc deficiency in obese patients:
1. The chronic inflammation in obese patients promotes
metallothionein and zinc-copper transporter expression,
resulting in the accumulation of the metal in hepatocytes
and adipocytes, responsible for decreased zinc serum
levels [16], 2. Inadequate intake of zinc resources with
high concentrations of this micronutrient might account
for zinc deficiency [17].
Furthermore, the prevalence of zinc deficiency is con-
sidered to be increased following bariatric surgery [13].
It has been revealed that 4–9% of bariatric patients ex-
perience zinc deficiency preoperatively and 20–24% after
18 months of bariatric operation [18–22]. A small-sized
randomized controlled trial of severe and morbidly
obese female patients who underwent RYGB reported a
significant decrease in zinc absorption from 32.3 to
13.6% after 6 months of RYGB [20]. Decreased zinc
absorption has been described by reducing the acidic en-
vironment following RYGB and SG [23].
However, Rojas et al. noted that zinc plasma levels
seemed to increase at 6 months after RYGB among se-
vere or morbidly obese women. They attributed such an
increase in zinc plasma levels to reducing inflammation
presented in their patients after the surgery. Nonethe-
less, they mentioned the “size of the exchangeable zinc
pool” as a suitable zinc status parameter, which signifi-
cantly decreased after RYGB [23].
We have shown that preoperative zinc serum levels
were significantly lower among bariatric patients with
40 ≤ BMI < 50 kg/m2, but we did not find an association
between zinc deficiency and BMI. Consistently, Moham-
madi et al. presented that morbidly obese patients with
Table 3 Zinc serum level and zinc deficiency during the pre- and postoperative period and in different groups of BMI, sex, and
underlying diseases
Zinc serum level (μg/dl), mean (SD) P-value Zinc deficiency, n (%) P-value
Preoperative 89.96 (21.04) a < 0.001 42 (10.2) –
At 3 months 89.99 (26.35) b 67 (16.2)
At 6 months 79.16 (18.39) a b 119 (28.8)
At 12 months 80.07 (17.92) a b 112 (27.1)
Group variables
BMI 0.044 0.372
35≤ BMI < 40 (n = 44) 95.79 (33.92) 4 (9.1)
40≤ BMI≤ 50 (n = 277) 87.97 (18.06)a 32 (11.6)
BMI > 50 (n = 92) 93.16 (20.77)a 6 (6.5)
Sex 0.038 0.029
Female (n = 344) 89.43 (21.99) 40 (11.6)
Male (n = 69) 92.58 (15.28) 2 (2.9)
HTN 0.210 0.689
Yes (n = 79) 87.37 (18.11) 9 (11.4)
No (n = 334) 90.57 (21.65) 33 (9.9)
Impaired FBS 0.227 0.027
Yes (n = 76) 87.70 (22.12) 13 (17.1)
No (n = 337) 90.47 (20.78) 29 (8.6)
DM Type II 0.503 0.047
Yes (n = 76) 92.25 (26.10) 3 (3.9)
No (n = 337) 89.44 (19.73) 39 (11.6)
Hyperlipidemia 0.584 0.308
Yes (n = 188) 90.78 (22.50) 16 (8.5)
No (n = 225) 89.27 (19.75) 26 (11.6)
Hypothyroidism 0.861 0.376
Yes (n = 91) 90.42 (20.95) 7 (7.7)
No (n = 322) 89.83 (21.09) 35 (10.9)
Abbreviations: BMI Body mass index, HTN Hypertension, FBS Fasting blood sugar, DM Diabetes mellitus, SD Standard deviation
a, and b indicate differences between groups
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BMI > 50 kg/m2have lower zinc serum levels while
there was no relation between zinc deficiency and an
increasing BMI [15]. However, it has been reported
that zinc serum levels before bariatric surgery seem
to be not related to BMI [13, 24, 25]. Differences in:
1) Cultural and geographical factors, which could
affect zinc deficiency, 2) study designs, 3) Data
distribution in BMI groups, and 4. dietary intake or
nutritional habits might potentially account for such
contrast findings between reports [15].
In our study, significantly lower serum zinc concentra-
tions and higher proportions of zinc deficiency were ob-
served in female patients before the surgery. Compared
to the male gender, higher rates of zinc deficiency in fe-
males could be attributed to different food patterns. Our
findings were in agreement with the Mohammadi et al.
study, which reported a similar pattern of zinc deficiency
in women patients while they found no significant asso-
ciation between zinc deficiency and sex [15].
Comparing zinc deficiency among different surgical
techniques, we found that 27.7% of the patients who re-
ceived mini-gastric bypass, 29.8% of RYGB, and 13.3% of
SG experienced zinc deficiency 12 months after surgery.
It can be also interpreted that zinc deficiency increased
18% among mini-gastric bypass and 19.2% among RYGB
patients from the preoperative period to 12months after
the surgery. However, no significant difference was ob-
served in zinc deficiency between groups of bariatric sur-
gery. Similar to our findings, Ferraz et al. observed no
significant difference in zinc deficiency between RYGB
and SG after 12 months of surgery (25.6% vs. 26.6%, re-
spectively). Nevertheless, they presented a substantial
difference between the surgeries at 24 months of follow-
up (RYGB: 30% vs. SG: 6.6%, P-value< 0.05) [10]. Con-
sistently, a higher prevalence of zinc deficiency among
RYGB patients compared to SG patients following 12
months of operation has been reported (40.7% vs. 18.8%,
respectively) [13]. Concerning such a significant differ-
ence, some explanations have been offered: 1. RYGB re-
sults in food transit deviation, 2. SG optimizes gastric
and proximal intestinal emptying time, which helps the
nutrients maintain more prolonged contact with the je-
junum and proximal ileum and leads to a better adhe-
sion to vitamin supplementation [10].
It has been reported that zinc deficiency could cause
different disorders, including skin disorders (e.g. bullous
dermatitis, psoriasiform and eczematous lesions), and be
fatal in severe cases [5, 26, 27]. In addition, the defi-
ciency of this micronutrient might contribute to poor
recovery during the postoperative period [15], so
preoperative baseline assessment and correction of zinc
deficiency could improve its prevalence in the postoper-
ative period. Previous studies suggested that zinc defi-
ciency might be prevented by administration of zinc
supplementations after bariatric surgery [19]. American
Association of Clinical Endocrinologists (AACE) guide-
lines has recommended taking a daily multivitamin sup-
plementation following obesity surgery to achieve
dietary reference intakes of zinc, which equal 8–11 mg
per day [28]. Despite the fact that our multivitamin and
mineral supplementations contained 30 mg of elemental
zinc, we observed a high prevalence of zinc deficiency
among our patients at the end of the study period.
However, the average zinc serum levels were within the
normal range in our patients during the postoperative
period.
Collectively, in the present cohort study, we assessed
the zinc status in a population of morbidly obese pa-
tients during the pre- and post-bariatric periods and
compared zinc deficiency between different groups of
bariatric surgeries within the first year of operation. We
observed a high prevalence of preoperative zinc defi-
ciency among morbidly obese patients who underwent
bariatric surgery, which increased during the postopera-
tive period. Besides, we found that mini-gastric bypass
and RYGB, compared to SG, showed higher zinc defi-
ciency rates at the end of the 12-month follow-up. How-
ever, we recommend an assessment of zinc serum levels
and prescribing zinc supplementation before bariatric
surgery to alleviate the prevalence of zinc deficiency
after the operation.
Strengths and limitations
Our study’s strengths included: 1. cohort study design
and the large study population, 2. we compared different
bariatric operations regarding zinc deficiency during the
12months of follow-up that helped us extend the cur-
rently available data concerning zinc status in different
bariatric surgical procedures. However, we encountered
some limitations. First, we were unsure of whether pa-
tients take their multivitamin and mineral supplementa-
tions on a daily and regular basis after the surgery.
Second, we did not evaluate confounding variables, in-
cluding albumin and C-reactive protein (CRP) serum
levels, which might affect the status of trace elements.
Third, different distribution of patients among bariatric
surgery categories, as well as the small number of pa-
tients in SG group, which could explain no significant
difference in zinc deficiency between bariatric surgery
groups. Forth, some modifiable variables might change
the zinc serum levels, including dietary intakes and food
habits. Fifth, patients’ compliance with the multivitamin
and mineral supplementations following the operation
was not recorded, which could possibly have an impact
on zinc serum levels.
To track the exact changes in the prevalence of zinc
deficiency among different types of bariatric surgeries
during the pre- and postoperative period, we suggest
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further prospective studies with long-term follow-ups,
assigning a similar number of patients into each group
of surgery and matching study participants regarding
nutritional habits, monitoring the patients to receive
their multivitamin and micronutrient supplementations
regularly after the operation, and evaluating the albumin
and CRP serum levels as potential confounders.
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